Cell and Gene Therapy 23/04/2019 The Patient’s Eye View of the Kymriah® Story Episode one of the Phacilitate Leaders World super plenary sessions, led by Anthony Davies, Dark Horse Consulting
Cell and Gene Therapy 16/04/2019 Keeping up with the pace of technology in an evolving field of... Alberto Santagostino, Lonza Pharma & Biotech's SVP Cell and Gene Technologies delivers a keynote presentation at Phacilitate Leaders World 2019...
Cell and Gene Therapy 29/03/2019 [VIDEO] Join the Advanced Therapies Revolution The story of advanced therapies and its monumental success stories told by industry leaders
Cell and Gene Therapy 18/03/2019 [WEBINAR] Developing an efficient, scalable cell and gene supply... This webinar unravelled complex cell and gene therapy supply chains with Be The Match, Skyland Analytics and Quick Personalized Logistics...
Cell and Gene Therapy 15/03/2019 What’s Next for Commercial Cell Therapy Manufacturing? Panellists from Invetech, bluebird bio, Juno Therapeutics and Hitachi Chemical Advanced Therapeutics Solutions (HCATS) discuss their vision for the...
Cell and Gene Therapy 01/03/2019 Phacilitate Automation Special Interest Group: 2018 Report The 2018 instalment of the Automation SIG identified the biggest hurdles facing our industry. This report summarises the onsite discussions and...
Cell and Gene Therapy 19/02/2019 Guest Blog: Are we Facing a COGs Crisis? Some insights from Phacilitate Leaders World 2019 by Stacey Johnson, CCRM
Cell and Gene Therapy 06/02/2019 The Top Ten Events in Advanced Therapies 2018 From CRISPR patent wars, IPOs and acquisitions to major deals in China; what would be on your top ten list of 2018?
Cell and Gene Therapy 24/01/2019 Behind the Scenes at Phacilitate Leaders World 2019 The story so far...
Cell and Gene Therapy 12/12/2018 Advanced Therapy Manufacturing: The Supply Chain Challenge Advanced therapy manufacturing and supply chains are anything but conventional
Cell and Gene Therapy 03/12/2018 Industrializing Advanced Therapies Changing mindsets to drive efficient manufacturing and commercialization of advanced therapies
Cell and Gene Therapy 28/11/2018 Demystifying the Common Technical Document Top tips for completing the common technical document for advanced therapies with Chris Bravery, Consulting Regulatory Scientist, Advanced...
Cell and Gene Therapy 28/11/2018 The Clinician’s Perspective on Patient Access Two healthcare professionals give their views on delivering advanced therapies in the clinic...
Cell and Gene Therapy 09/11/2018 Understanding Global, Complex Supply Chains for Advanced Therapies A snapshot of the supply chain, logistics and customs challenges for advanced therapies
Cell and Gene Therapy 08/10/2018 FDA Regulatory Reform? An interview with Anthony Davies, Founder and CEO, Dark Horse Consulting
